Female sexual dysfunction, or FSD, has long been under-diagnosed and under-treated in clinical practice. But in recent months, notable leaders in women's health have stepped forward to push for new recognition and prioritization of this disorder to the forefront of the FDA. On this program, host Dr. Matt Birnholz is joined by one of those leaders who helped jumpstart this critical development: Dr. Michael Krychman, Executive Director of the Southern California Center for Sexual Health in Newport Beach, CA.
The National Campaign to Recognize Female Sexual Dysfunction

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Sponsored by
Overview
Female sexual dysfunction, or FSD, has long been under-diagnosed and under-treated in clinical practice. But in recent months, notable leaders in women's health have stepped forward to push for new recognition and prioritization of this disorder to the forefront of the FDA. On this program, host Dr. Matt Birnholz is joined by one of those leaders who helped jumpstart this critical development: Dr. Michael Krychman, Executive Director of the Southern California Center for Sexual Health in Newport Beach, CA.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?